News
Recursion: Shaking Up The Biopharma Landscape With A Bold, Data-Driven Blueprint Jul. 17, 2023 5:04 PM ET Recursion Pharmaceuticals, Inc. (RXRX) Stock NVDA , RXRX 21 Comments 4 Likes Nelson Alves ...
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
--Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today the release of OpenPhenom-S/16, a publicly available foundation model in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback